Altered splicing and cytoplasmic levels of tRNA synthetases in SF3B1-mutant myelodysplastic syndromes as a therapeutic vulnerability
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Altered splicing and cytoplasmic levels of tRNA synthetases in SF3B1-mutant myelodysplastic syndromes as a therapeutic vulnerability ; volume:9 ; number:1 ; day:25 ; month:2 ; year:2019 ; pages:1-13 ; date:12.2019
Scientific reports ; 9, Heft 1 (25.2.2019), 1-13, 12.2019
- Klassifikation
-
Naturwissenschaften
- Urheber
-
Liberante, Fabio Giuseppe
Lappin, Katrina
Barros, Eliana M.
Vohhodina, Jekaterina
Grebien, Florian
Savage, Kienan I.
Mills, Kenneth Ian
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-019-39591-7
- URN
-
urn:nbn:de:101:1-2019031820113926514872
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 08:44 UTC
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Liberante, Fabio Giuseppe
- Lappin, Katrina
- Barros, Eliana M.
- Vohhodina, Jekaterina
- Grebien, Florian
- Savage, Kienan I.
- Mills, Kenneth Ian
- SpringerLink (Online service)
Ähnliche Objekte (12)
Myelodysplastic syndromes
Myelodysplastic syndromes
Epigenetic therapy in myelodysplastic syndromes
Myelodysplastic syndromes : with 87 tabeles
Bone marrow apoptosis in myelodysplastic syndromes
Myelodysplastic syndromes: Where do we stand?
Bone marrow apoptosis in myelodysplastic syndromes
Myelodysplastic syndromes current treatment algorithm 2018
Emerging Therapies for the Myelodysplastic Syndromes
Drug development in higher-risk myelodysplastic syndromes
Genomics of myelodysplastic syndromes in children and adolescents
Cardiovascular risk in elderly Egyptians with myelodysplastic syndromes
Myelodysplastic syndromes
Myelodysplastic syndromes
Epigenetic therapy in myelodysplastic syndromes
Myelodysplastic syndromes : with 87 tabeles
Bone marrow apoptosis in myelodysplastic syndromes
Myelodysplastic syndromes: Where do we stand?
Bone marrow apoptosis in myelodysplastic syndromes
Myelodysplastic syndromes current treatment algorithm 2018
Emerging Therapies for the Myelodysplastic Syndromes
Drug development in higher-risk myelodysplastic syndromes
Genomics of myelodysplastic syndromes in children and adolescents
Cardiovascular risk in elderly Egyptians with myelodysplastic syndromes
Myelodysplastic syndromes
Myelodysplastic syndromes
Epigenetic therapy in myelodysplastic syndromes
Myelodysplastic syndromes : with 87 tabeles
Bone marrow apoptosis in myelodysplastic syndromes
Myelodysplastic syndromes: Where do we stand?
Bone marrow apoptosis in myelodysplastic syndromes
Myelodysplastic syndromes current treatment algorithm 2018
Emerging Therapies for the Myelodysplastic Syndromes
Drug development in higher-risk myelodysplastic syndromes
Genomics of myelodysplastic syndromes in children and adolescents